Burren Capital Advisors’s Amedisys AMED Stock Holding History

Burren Capital Advisors’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-13,949	Closed	-$1.37M	–	17
2025 Q2	$1.37M	Buy	13,949 +7,905	+131%	+$748K	4.01%	11
2025 Q1	$560K	Sell	6,044 -17,000	-74%	-$1.57M	2%	15
2024 Q4	$1.54M	Buy	+23,044	New	+$2.12M	9.2%	5

Other funds holding AMED

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

MCI

MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Burren Capital Advisors's AMED Position: Q3 2025 in Review

Burren Capital Advisors sold out of Amedisys (AMED) in Q3 2025, closing a stake of 13,949 shares — an estimated $1.37M sold.

Burren Capital Advisors first reported a position in AMED in Q4 2024 and held it in 3 quarters. The position peaked at $1.54M in Q4 2024. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

Burren Capital Advisors reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
Burren Capital Advisors sold 13,949 Amedisys shares in Q3 2025, an estimated $1.37M.
Burren Capital Advisors first reported a position in Amedisys in Q4 2024 and held it in 3 quarters.
Burren Capital Advisors's Amedisys position peaked at $1.54M in Q4 2024.
4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Burren Capital Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.